Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirum Pharmaceuticals, Inc.

43.23
-1.7700-3.93%
Post-market: 44.501.27+2.94%17:34 EDT
Volume:464.32K
Turnover:20.19M
Market Cap:2.12B
PE:-23.36
High:44.99
Open:44.86
Low:43.13
Close:45.00
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

THOMSON REUTERS
·
21 Feb

High Growth Tech Stocks in United States to Watch

Simply Wall St.
·
19 Feb

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
11 Feb

Netflix Near Record High, So Are These Stocks: Build Your Growth Stock Watchlist With Top Stock Screens

Blockhead
·
27 Jan

Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
24 Jan

Top Analyst Reports for Home Depot, RTX & Applied Materials

Zacks
·
17 Jan

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results

Zacks
·
16 Jan

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.
·
14 Jan

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

Zacks
·
14 Jan

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

THOMSON REUTERS
·
13 Jan

Mirum Pharmaceuticals Inc: 2025 Expected Global Net Product Sales of $420 Mln to $435 Mln

THOMSON REUTERS
·
13 Jan

Mirum Pharmaceuticals: Expect 2024 Net Product Sales of About $336 Mln

THOMSON REUTERS
·
13 Jan

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
10 Jan

Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Path To Profitability

Simply Wall St.
·
26 Dec 2024

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?

Zacks
·
12 Dec 2024

BRIEF-Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
10 Dec 2024

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
10 Dec 2024

Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities

TipRanks
·
06 Dec 2024

Mirum Shares Surge More Than 90% in 6 Months: Here's Why

Zacks
·
29 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
21 Nov 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."